| Age, mean (median, IQR), years |
6.1±3.4 (4.4, 0.01–17.8) |
| Age groups, n (%) |
|
| 0–1 |
41 (27.7) |
| >1–5 |
30 (20.2) |
| >5–10 |
18 (12.1) |
| >10–15 |
34 (23.0) |
| >15 |
25 (17.0) |
| Gender |
|
| Female |
83 (56.0) |
| Male |
65 (43.9) |
| Diagnosis |
|
| Dilative cardiomyopathy |
76 (51.3) |
| Non-compaction cardiomyopathy |
1 (0.7) |
| Myocarditis |
33 (22.2) |
| Arrhythmogenic cardiomyopathy |
1 (0.7) |
| Post-correction of congenital heart disease |
29 (19.6) |
| Ischemic heart failure |
5 (3.3) |
| Tumor |
1 (0.7) |
| Graft failure |
2 (1.3) |
| Duration of disease before VAD implantation, years |
1.59±0.29 (0.33, 1 day – 14 years) |
| Cardiopulmonary resuscitation prior to VAD |
49 (33.1) |
| ECMO prior to VAD |
16 (10.8) |
| Duration of ECMO (IQR), days |
11.4±5.1 [5, 2–57] |
| Type of support |
|
| Left VAD |
92 (62.1) |
| Right VAD |
1 (0.7) |
| Biventricular VAD |
55 (37.1) |
| Duration of VAD support mean (median, IQR), days |
88.3±41.6 (23.3, 1–700) |
